Cargando…
Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema
Acquired angioedema is often associated with significant morbidity. An underlying lymphatic malignancy, autoimmune disorder, adenocarcinoma, or other malignancy may be present. Screening for these disorders should occur in all patients with acquired angioedema as treatment may result in resolution o...
Autores principales: | Kaur, Ravdeep, Williams, Aerik Anthony, Swift, Catherine Baker, Caldwell, Jason W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259552/ https://www.ncbi.nlm.nih.gov/pubmed/25506230 http://dx.doi.org/10.2147/JAA.S68548 |
Ejemplares similares
-
A case of acquired angioedema associated with Waldenstrom’s macroglobulinemia treated with rituximab
por: Rizk, Caroline, et al.
Publicado: (2014) -
PB2278: ACQUIRED ANGIOEDEMA ASSOCIATED WITH LYMPHOPROLIFERATIVE DISORDERS: A CASE SERIES
por: Ng, Jun Yen, et al.
Publicado: (2023) -
Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen
por: Wu, Kathie, et al.
Publicado: (2023) -
Acquired angioedema
por: Cicardi, Marco, et al.
Publicado: (2010) -
Age Characteristics and Concomitant Diseases in Patients with Angioedema
por: Dermendzhiev, Svetlan, et al.
Publicado: (2019)